Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with <i>KRAS G12C</i> mutationJayesh Desai, Manish Patel, Erminia Massarelli et al.|Cancer Research|2023Cited by 10
Abstract CT022: Divarasib plus migoprotafib combination treatment in patients with <i>KRAS G12C</i>-positive non-small cell lung cancer (NSCLC)Jia Luo, Myung‐Ju Ahn, Adrian G. Sacher et al.|Cancer Research|2025Cited by 2